Fairfax Financial Holdings Limited

Fairfax reported second-quarter 2026 operating income from insurance and reinsurance of $1.1 billion, underwriting income of $459 million versus $427 million a year ago, interest and dividend income of $737 million versus $660 million, profits of associates of $43 million versus $131 million, and net investment gains of $769 million. Net earnings were $1.4 billion in Q2 and $2.1 billion for the first six months. Book value per share ended at $1,304.39, up 4.8% from year-end 2025 adjusted for the $15 dividend. Gross premium written was $9.4 billion, up 4.1% year over year, and the combined ratio was 93.1% versus 93.3% last year. Management did not provide formal quarterly or full-year EPS guidance, but said associate income plus consolidated investments is running above the roughly $1 billion level they had previously referenced. They also said interest and dividend income run rate is about 5%, and emphasized that softening pricing, particularly in North American property, is pressuring growth while international operations continue to grow well.

Peter Clarke struck a confident but measured tone, calling it another strong quarter and emphasizing disciplined underwriting and long-term capital allocation. He highlighted the company’s diversification, saying softening is most acute in property and North America, while international operations are growing at a good clip and now represent a larger share of business. He also framed Fairfax’s approach as patient and profitability-focused rather than chasing premium growth.

Amy Sherk walked through the main transaction and balance-sheet items, including the sale of 23.1% of the Poseidon stake for $1.9 billion and an $838 million realized gain, the Kennedy-Wilson privatization, and pending deals involving Andrew Peller, Sleep Number, IIFL Capital, and Eurobank/Eurolife. She said holding company cash and investments were $2.3 billion, the $2 billion revolving credit facility was undrawn, and there was another $2.2 billion of fair value in investments in associates and market-traded consolidated noninsurance companies. She also noted total debt to total capital, excluding noninsurance companies, rose to 28% from 26.2%, and common shareholders’ equity was $26 billion after buybacks, dividends, and foreign currency translation losses.

Analysts focused on softening insurance pricing, especially whether it is spreading from property into casualty; management said the pressure is still mainly on property, with some possible spillover into casualty, and that Fairfax is shifting toward higher-margin business. Another question focused on the Fairfax stock TRS sale; Clarke said it was not a signal the stock is unattractive, noting Fairfax still bought back almost 1 million shares and continues to hold about 1.3 million TRS shares. Questions on leverage and float drew a response that float is being built over the long term and that recent debt issuance largely replaced preferred shares with 30-year debt on more favorable terms.